Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RED EYE TRIPLE ACTION - Health Canada Drug Approval Details

Approvals/Health Canada/RED EYE TRIPLE ACTION

Authorized

STANDARD

RED EYE TRIPLE ACTION

johnson & johnson inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: f16d6f94adf82113
Company: johnson & johnson inc
Type: Standard

Approval Details

Approval Id: f16d6f94adf82113
Drug Approval Canada Name: RED EYE TRIPLE ACTION
Product Name: RED EYE TRIPLE ACTION
Status: Marketed
Status Date: 2022-03-15
Original Market Date: 2022-03-15
Din: 02518201
Drug Class: Human
Dosage Form: Drops
Route Of Administration: Ophthalmic
Schedule: OTC
Ahfs: 52:32.00
Atc Original: S01GA52 TETRYZOLINE, COMBINATIONS
Atc Name: s 01 ga 52
Aig Number: 0227167001
Company Name: johnson & johnson inc
Company Address: 88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2

Active Ingredients

TETRAHYDROZOLINE HYDROCHLORIDE

0.05 % / W/V

POLYETHYLENE GLYCOL 400

1 % / V/V

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f16d6f94adf82113

Type

Standard

Back to Health Canada Approvals